Skip to main content
Back to RA Capital Management

RA Capital Management's Health Diagnostics Portfolio

Browse 7 Health Diagnostics companies funded by RA Capital Management. See funding amounts, founder contacts, and investment details.

Health Diagnostics Companies
7
Total Funding in Health Diagnostics
$519.0M

Health Diagnostics Portfolio Companies (7)

Export
BiotechnologyHealth CareHealth DiagnosticsMedical

Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.

Foster City, United States
April 2026
$48.0M
Convertible Note

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsTherapeutics

SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.

Charlestown, United States
April 2024
$48.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsManufacturing

Nature’s Toolbox is a biotechnology company that provides a proprietary host-independent biological manufacturing and development platform.

Rio Rancho, United States
December 2025
$10.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyGeneticsHealth DiagnosticsTherapeutics

NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.

Waltham, United States
November 2025
$3.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.

Philadelphia, United States
January 2026
$135.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsOncologyPersonal Health

Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.

South San Francisco, United States
November 2025
$75.0M
Corporate Round

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsNeurosciencePharmaceutical

Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.

New Haven, United States
November 2025
$200.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Explore RA Capital Management's Full Portfolio

View all companies funded by RA Capital Management across every industry and funding stage.

View Full RA Capital Management Portfolio